Center for Inherited Blood Disorders

Orange, California 92868-4748

3 studies enrolling now · 8 studies all time

What they study most

Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors, Hemophilia A, Hemophilia A With Inhibitors, Hemophilia B, Hemophilic Arthropathy, Sickle Cell Disease, Von Willebrand Diseases

Studies at this site

• A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A — Recruiting now
• Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B — Recruiting now
• A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A — Recruiting now
• ATHN 9: Severe VWD Natural History Study — Completed
• Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors — Running, not enrolling
• Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD — Stopped early
• Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy — Stopped early
• A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study) — Completed